Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
9 studies found for:    Open Studies | "Hidradenitis Suppurativa"
Show Display Options
Rank Status Study
1 Recruiting Effectiveness of Adalimumab in Moderate to Severe HidrAdenitis SuppuRativa Patients - a Multi cOuNtry studY in Real Life Setting
Condition: Hidradenitis Suppurativa
Intervention:
2 Recruiting Safety and Efficacy of Humira (Adalimumab) for Hidradenitis Suppurativa (HS) Peri-Surgically (SHARPS Study)
Condition: Hidradenitis Suppurativa
Interventions: Drug: Adalimumab;   Drug: Placebo
3 Recruiting Single Center Study of Apremilast for the Treatment of Hidradenitis Suppurativa
Condition: Hidradenitis Suppurativa
Intervention: Drug: Apremilast
4 Recruiting Open-label Study of Adalimumab in Japanese Subjects With Hidradenitis Suppurativa
Condition: Hidradenitis Suppurativa
Intervention: Drug: Adalimumab
5 Recruiting A Randomized Controlled Trial Evaluating the Efficacy of Intralesional Triamcinolone in Hidradenitis Suppurativa.
Condition: Hidradenitis Suppurativa
Interventions: Drug: Triamcinolone Acetonide 10mg/mL;   Drug: Triamcinolone Acetonide 40mg/mL;   Drug: Normal Saline
6 Recruiting Post Marketing Observational Study (PMOS) to Assess Quality of Life in Swedish Hidradenitis Suppurativa (HS) Patients
Condition: Hidradenitis Suppurativa
Intervention: Biological: Adalimumab
7 Not yet recruiting Effect of Sclerotherapy on Fistulas and Sinus Tracts in Hidradenitis Suppurativa
Condition: Hidradenitis Suppurativa
Interventions: Drug: 23.4% Hypertonic saline;   Drug: Saline
8 Recruiting Canadian Humira Post Marketing Observational Epidemiological Study : Assessing Humira Real-life Effectiveness and Impact on HS Burden of Illness
Condition: Hidradenitis Suppurativa (HS)
Intervention:
9 Recruiting Group Psychotherapy for Patients With Hidradenitis Suppurativa: Effects in Quality of Life
Condition: Hidradenitis
Intervention: Behavioral: psychotherapy

Study has passed its completion date and status has not been verified in more than two years.